This is supported by the fact that within human breast cancer primary tumors, a subpopulation of cells expressing CD44+CD24−/low, having stem cell characteristics, were able to form tumors when only 200 of these cells were implanted in non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice [81]. The gene discussed is CD44; the disease is breast carcinoma.